Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle

被引:77
作者
Moriyama, A
Shimoya, K
Ogata, I
Kimura, T
Nakamura, T
Wada, H
Ohashi, K
Azuma, C
Saji, F
Murata, Y
机构
[1] Osaka Univ, Dept Gynecol & Obstet, Fac Med, Osaka 5650871, Japan
[2] Osaka Police Hosp, Dept Gynecol & Obstet, Tennouji Ku, Osaka 5438502, Japan
[3] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gynecol, Higashinari Ku, Osaka 5370025, Japan
关键词
cervical mucus; ovulation; secretory leukocyte protease inhibitor (SLPI);
D O I
10.1093/molehr/5.7.656
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Secretory leukocyte protease inhibitor (SLPI) is a potent inhibitor of human leukocyte elastase, SLPI transcripts in the cervical tissue were detected during the menstrual cycle by reverse transcription-polymerase chain reaction (RT-PCR). Western blot analysis revealed that the intensity of SLPI protein in cervical tissue in the ovulatory phase was stronger than in other phases. Immunohistochemistry using an anti-SLPI polyclonal antibody revealed positive staining in the epithelial cells of the endocervix. Western blot analysis also revealed that SLPI protein was present in the cervical mucus. Again the intensity of SLPI protein in the ovulatory phase was stronger than that in the follicular phase. The SLPI concentrations and SLPI/elastase ratios in the cervical mucus of women in the ovulatory phase were significantly higher than in the follicular and luteal phases. The SLPI and elastase concentrations in the cervical mucus were positively correlated, No significant difference was found in the SLPI serum concentrations of women during the menstrual cycle. These results suggest that production of SLPI from cervical epithelial cells during the ovulatory phase may be important for protection from the effects of elastase.
引用
收藏
页码:656 / 661
页数:6
相关论文
共 23 条
[1]  
ABBINANTE NJ, 1993, AM J PHYSIOL, V265, pL286
[2]   EXPRESSION OF THE SECRETORY LEUKOPROTEASE INHIBITOR GENE IN EPITHELIAL-CELLS [J].
ABE, T ;
KOBAYASHI, N ;
YOSHIMURA, K ;
TRAPNELL, BC ;
KIM, H ;
HUBBARD, RC ;
BREWER, MT ;
THOMPSON, RC ;
CRYSTAL, RG .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) :2207-2215
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   LOCALIZATION AND QUANTITATION OF A LOW-MOLECULAR WEIGHT PROTEINASE-INHIBITOR, ANTI-LEUKOPROTEASE, IN THE HUMAN-UTERUS [J].
CASSLEN, B ;
ROSENGREN, M ;
OHLSSON, K .
HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1981, 362 (07) :953-961
[5]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[6]   ABILITY OF CERVICAL MUCUS TO ACT AS A BARRIER AGAINST BACTERIA [J].
ENHORNING, G ;
HULDT, L ;
MELEN, B .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1970, 108 (04) :532-+
[7]  
FRYKSMARK U, 1989, Rhinology (Utrecht), V27, P97
[8]   SECRETORY LEUKOCYTE PROTEASE INHIBITOR IN THE CERVICAL-MUCUS AND IN THE FETAL MEMBRANES [J].
HELMIG, R ;
ULDBJERG, N ;
OHLSSON, K .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1995, 59 (01) :95-101
[9]   Increased interleukin-1 and interleukin-1 receptor antagonist levels in cervical mucus in the ovulatory phase in comparison with the follicular phase [J].
Kanai, T ;
FukudaMiki, M ;
Shimoya, K ;
Azuma, C ;
Hashimoto, K ;
Nobunaga, T ;
Tokugawa, Y ;
Tsujimoto, M ;
Saji, F ;
Murata, Y .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1997, 43 (03) :166-170
[10]   SERUM SECRETORY LEUKOPROTEASE INHIBITOR LEVELS TO DIAGNOSE PNEUMONIA IN THE ELDERLY [J].
KIDA, K ;
MIZUUCHI, T ;
TAKEYAMA, K ;
HIRATSUKA, T ;
JINNO, S ;
HOSODA, K ;
IMAIZUMI, A ;
SUZUKI, Y .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (06) :1426-1429